> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Drug Compounding Facility Fees
- URL: https://www.fdaweb.com/comments-sought-on-drug-compounding-facility-fees/
- Published: 2017-06-15T12:00:00.000Z
- Updated: 2026-09-14T22:29:43.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138942

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act—OMB Control Number 0910–0776.” To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-06-15/pdf/2017-12353.pdf?ref=fdaweb.com).